Medifast Confirms Appointment of Nicholas Johnson as Chief Executive Officer
Medifast has formally appointed Nicholas Johnson as Chief Executive Officer, effective June 1, 2026. Johnson succeeds Dan Chard, who will step down as CEO but remain as Chairman of the Board to provide strategic oversight.
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.